SCHEMBL23944373

SCHEMBL23944373

c1ccc(-c2nc(-c3ccc(-c4cncc5oc6cc7ccccc7cc6c45)cc3)nc(-c3ccc4ccccc4c3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
CYP1A2 P05177 2/20 0.41
MEN1 O00255 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KMT2A Q03164 2/20 0.41
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
CYP11B1 P15538 5/20 0.38
CYP11B2 P19099 5/20 0.38
CYP17A1 P05093 1/20 0.38
CYP19A1 P11511 1/20 0.38
MAPK9 P45984 2/20 0.37
MAPK10 P53779 2/20 0.37
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23944378 0.96 PRKCZ (0.38) KDM4ECYP1A2MEN1ALDH1A1KMT2A
SCHEMBL24762187 0.95 KDM4E (0.41) KDM4ECYP1A2MEN1ALDH1A1KMT2A
SCHEMBL23944358 0.95 PRKCZ (0.38) KDM4ECYP1A2MEN1ALDH1A1KMT2A
SCHEMBL23944559 0.94 KDM4E (0.40) KDM4ECYP1A2MEN1ALDH1A1KMT2A
SCHEMBL23944537 0.93 KDM4E (0.39) KDM4ECYP1A2MEN1ALDH1A1KMT2A
SCHEMBL24762323 0.92 KDM4E (0.39) KDM4ECYP1A2MEN1ALDH1A1KMT2A
SCHEMBL23944820 0.92 CYP11B1 (0.38) KDM4ECYP1A2MEN1ALDH1A1KMT2A
SCHEMBL23944453 0.92 PRKCZ (0.35) KDM4ECYP1A2MEN1ALDH1A1KMT2A
SCHEMBL24762964 0.92 PRKCZ (0.35) KDM4ECYP1A2MEN1ALDH1A1KMT2A
SCHEMBL23944929 0.91 KDM4E (0.39) KDM4ECYP1A2MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220402928-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2022-12-22 US disclosed
WO-2021210910-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220402928-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, CRY1, CRY2 KDM4E 3730/4885CYP1A2 241/4885MEN1 1025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.